Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure
Mintu Nath(University of Leicester), Nilesh J. Samani(University of Leicester), Manolo Papakonstantinou(University of Leicester), John G.F. Cleland(University of Glasgow), Gerasimos Filippatos(National and Kapodistrian University of Athens), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Thomas R. Webb(University of Leicester), Stephen E. Hamby(University of Leicester), Federica M. Marelli‐Berg(Queen Mary University of London), Marco Metra(Vita-Salute San Raffaele University), Sean May, Adriaan A Voors(University Medical Center Groningen), Chim C. Lang(University of Dundee), Dirk J. van Veldhuisen(University Medical Center Groningen), Andrea Koekemoer(University of Leicester), Simon P.R. Romaine(University of Leeds), Leong L. Ng(University of Leicester), Christopher P. Nelson(Glenfield Hospital), James A. Timmons(University of Miami), Stefan D. Anker(Charité - Universitätsmedizin Berlin), Marcos Castellanos‐Uribe(University of Nottingham)
Cited by 16
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k